Shokrani, Marjan
Askari, Sanaz
Eissazade, Negin
Shariat, Seyed Vahid
Shariati, Behnam
Yarahmadi, Masoomeh
Shalbafan, Mohammadreza
Funding for this research was provided by:
Iran University of Medical Sciences (98-4-75-16914)
Article History
Received: 12 March 2023
Accepted: 12 September 2023
First Online: 21 September 2023
Declarations
:
: The trial was approved by the ethics committee of the Iran University of Medical Sciences institutional review board (IR.IUMS.REC.1399.101) and carried out based on the Declaration of Helsinki and subsequent revisions. Written informed consent was obtained from all participants. Patients were reassured that their participation was voluntary and that they had the right to return to their usual treatment at any point in the study. The trial was registered at the Iranian Registry of Clinical Trials on 14/07/2020 (ExternalRef removed; IRCT ID: IRCT20170123032145N5).
: Not applicable.
: The authors declare no competing interests.